.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Moodys
Medtronic
Mallinckrodt
Harvard Business School
Cipla
Accenture
Federal Trade Commission
McKesson
Cantor Fitzgerald

Generated: September 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204677

« Back to Dashboard
NDA 204677 describes NEURACEQ, which is a drug marketed by Piramal Imaging and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the NEURACEQ profile page.

The generic ingredient in NEURACEQ is florbetaben f-18. One supplier is listed for this compound. Additional details are available on the florbetaben f-18 profile page.

Summary for NDA: 204677

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1

Pharmacology for NDA: 204677

Mechanism of ActionPositron Emitting Activity

Suppliers and Packaging for NDA: 204677

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NEURACEQ
florbetaben f-18
SOLUTION;INTRAVENOUS 204677 NDA Piramal Imaging, SA 54828-001 54828-001-30 1 VIAL, MULTI-DOSE in 1 CONTAINER (54828-001-30) > 30 mL in 1 VIAL, MULTI-DOSE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INTRAVENOUSStrength30ML (1.4-135mCi/ML)
Approval Date:Mar 19, 2014TE:RLD:Yes
Regulatory Exclusivity Expiration:Mar 21, 2019
Regulatory Exclusivity Use:NEW CHEMICAL ENTITY
Patent:► SubscribePatent Expiration:Mar 18, 2029Product Flag?YSubstance Flag?YDelist Request?
Patented Use:NEURACEQ IS A RADIOACTIVE DIAGNOSTIC AGENT FOR POSITRON EMISSION TOMOGRAPHY (PET) IMAGING OF THE BRAIN TO ESTIMATE P-AMYLOID NEURITIC PLAQUE DENSITY IN ADULT PATIENTS WITH COGNITIVE IMPAIRMENT


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Covington
Harvard Business School
Express Scripts
Johnson and Johnson
Fuji
Cipla
Chinese Patent Office
Fish and Richardson
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot